Lord & Richards Wealth Management LLC Has $1.56 Million Position in Chemed Corporation $CHE

Lord & Richards Wealth Management LLC raised its position in Chemed Corporation (NYSE:CHEFree Report) by 51.9% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 3,477 shares of the company’s stock after acquiring an additional 1,188 shares during the period. Chemed comprises approximately 1.4% of Lord & Richards Wealth Management LLC’s holdings, making the stock its 24th largest holding. Lord & Richards Wealth Management LLC’s holdings in Chemed were worth $1,557,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently bought and sold shares of the business. Creekmur Asset Management LLC bought a new stake in Chemed in the second quarter valued at about $28,000. First Horizon Corp acquired a new position in shares of Chemed in the 3rd quarter worth approximately $31,000. Pilgrim Partners Asia Pte Ltd acquired a new position in Chemed in the third quarter worth $45,000. Parkside Financial Bank & Trust raised its holdings in shares of Chemed by 86.3% in the second quarter. Parkside Financial Bank & Trust now owns 95 shares of the company’s stock valued at $46,000 after buying an additional 44 shares during the last quarter. Finally, HM Payson & Co. raised its stake in shares of Chemed by 35.5% in the third quarter. HM Payson & Co. now owns 103 shares of the company’s stock worth $46,000 after acquiring an additional 27 shares during the last quarter. Institutional investors own 95.85% of the company’s stock.

Chemed Stock Up 1.9%

CHE stock opened at $435.27 on Tuesday. Chemed Corporation has a twelve month low of $408.42 and a twelve month high of $623.60. The business has a 50 day moving average price of $436.52 and a two-hundred day moving average price of $442.11. The company has a market cap of $6.16 billion, a price-to-earnings ratio of 23.02, a P/E/G ratio of 2.08 and a beta of 0.44.

Chemed Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, December 5th. Investors of record on Monday, November 17th were issued a dividend of $0.60 per share. The ex-dividend date was Monday, November 17th. This represents a $2.40 dividend on an annualized basis and a yield of 0.6%. Chemed’s dividend payout ratio (DPR) is presently 12.69%.

Analyst Ratings Changes

A number of equities research analysts have recently weighed in on the company. Weiss Ratings restated a “hold (c-)” rating on shares of Chemed in a research report on Wednesday, January 21st. Zacks Research upgraded shares of Chemed from a “strong sell” rating to a “hold” rating in a report on Thursday, October 30th. Royal Bank Of Canada reduced their target price on Chemed from $589.00 to $572.00 and set an “outperform” rating on the stock in a report on Monday, November 10th. Finally, Jefferies Financial Group lowered shares of Chemed from a “buy” rating to a “hold” rating in a research note on Thursday, January 22nd. Three investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $555.50.

Get Our Latest Stock Analysis on Chemed

Insider Activity

In other news, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction that occurred on Monday, November 24th. The stock was sold at an average price of $437.55, for a total transaction of $875,100.00. Following the completion of the transaction, the chief executive officer directly owned 94,197 shares in the company, valued at approximately $41,215,897.35. The trade was a 2.08% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 3.29% of the stock is currently owned by insiders.

Chemed Company Profile

(Free Report)

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.

Read More

Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Corporation (NYSE:CHEFree Report).

Institutional Ownership by Quarter for Chemed (NYSE:CHE)

Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.